SlideShare uma empresa Scribd logo
1 de 8
Baixar para ler offline
Cardiogenic shock is a state in which a weakened heart isn't able to
pump enough blood to meet the body's needs. It is a medical
emergency and is fatal if not treated right away. The most common
cause of cardiogenic shock is damage to the heart muscle from a
severe heart attack.
Not everyone who has a heart attack develops cardiogenic shock. In
fact, less than 10 percent of people who have a heart attack
develop it. But when cardiogenic shock does occur, it's very
dangerous. For people who die from a heart attack in a hospital,
cardiogenic shock is the most common cause.
The medical term "shock" refers to a state in which not enough
blood and oxygen reach important organs in the body, such as the
brain and kidneys. In a state of shock, a person's blood pressure is
very low.
When a person is in shock (from any cause), not enough blood or
oxygen is reaching the body's organs. If shock lasts more than several
minutes, the lack of oxygen to the organs starts to damage them. If
shock isn't treated quickly, the organ damage can become
permanent, and the person can die.
Pathophysiology
The most common initiating event in cardiogenic shock is AMI. Dead
myocardium does not contract, and classical teaching has been that
when more than 40% of the myocardium is irreversibly damaged
(particularly, the anterior cardiac wall), cardiogenic shock may
result. On a mechanical level, a marked decrease in contractility
reduces the ejection fraction and cardiac output. These lead to
increased ventricular filling pressures, cardiac chamber dilatation,
and ultimately univentricular or biventricular failure that result in
systemic hypotension and/or pulmonary edema.
A systemic inflammatory response syndrome–type mechanism has
been implicated in the pathophysiology of cardiogenic shock.
Elevated levels of white blood cells, body temperature,
complement, interleukins, and C-reactive protein are often seen in
large myocardial infarctions. Similarly, inflammatory nitric oxide
synthetase (iNOS) is also released in high levels during myocardial
stress. iNOS induces nitric oxide production, which may uncouple
calcium metabolism in the myocardium resulting in a stunned
myocardium. Additionally, iNOS leads to the expression of
interleukins, which may themselves cause hypotension.
Myocardial ischemia causes a decrease in contractile function, which
leads to left ventricular dysfunction and decreased arterial pressure;
these, in turn, exacerbate the myocardial ischemia. The end result is
a vicious cycle that leads to severe cardiovascular decompensation.
Causes
 The vast majority of cases of cardiogenic shock in adults are
due to acute myocardial ischemia.
 Systolic -Beta-blocker overdose, calcium channel blocker
overdose, myocardial contusion, respiratory acidosis,
hypocalcemia, hypophosphatemia, and cardiotoxic drugs (eg,
doxorubicin [Adriamycin])
 Diastolic - Ventricular hypertrophy and restrictive
cardiomyopathies
 After load -Aortic stenosis, hypertrophic cardiomyopathy,
dynamic outflow obstruction, aortic coarctation, and malignant
hypertension

 Valvular/structural -Mitral stenosis, endocarditis, myocarditis,
mitral or aortic regurgitation, atrial myxoma or thrombus,
pericardial tamponade & pulmonary embolism.
 Risk factors for the development of cardiogenic shock include
preexisting myocardial damage or disease (eg, diabetes,
advanced age, previous AMI(acute MI), AMI (eg, Q-wave, large
or anterior wall AMIs), congenital heart disease, and
dysrhythmia.
Signs & symptoms:
 Profuse sweating, moist skin
 Tachycardia & tachypnea
 Restlessness, agitation, confusion due to decreased cerebral
perfusion and subsequent hypoxia.
 Skin that feels cool to the touch
 Pale skin color or blotchy (mottled) skin
 Rapid & Weak (thready) pulse
 Decreased mental status - Loss of ability to concentrate & Loss
of alertness
 Decreased or no urine output
 Hypotension due to decrease in cardiac output
 Distended jugular veins due to increased jugular venous
pressure.
DiagnosisBlood pressure. very low blood pressure, the most common sign of
shock.
ECG (electrocardiogram). diagnose severe heart attack & and
monitor heart's condition.
Chest X-ray.. A chest X-ray shows whether the heart is enlarged or
whether there is fluid in the lungs, which can be signs of cardiogenic
shock.
Echocardiography. This test uses sound waves to create a moving
picture of your heart. Echocardiography provides information about
the size and shape of your heart and how well your heart chambers
and valves are working. The test also can identify areas of heart
muscle that aren't contracting normally. Not enough blood is flowing
to these areas.
Coronary angiography. passing a catheter (a thin, flexible tube)
through an artery in leg or arm to heart. The catheter can measure
the pressure inside the various chambers of your heart. A dye that
can be seen on X-ray is injected into the blood through the tip of the
catheter. The dye allows to study the flow of blood through the heart
and blood vessels and see any blockages that exist.
Arterial blood gas measurement. In this test, a blood sample is taken
from an artery to measure oxygen, carbon dioxide, and pH (acidity)
in the blood..
Cardiac enzymes. When cells in the heart die, they release enzymes
into the blood called markers or biomarkers. Measuring these
markers can show whether the heart is damaged and the extent of
the damage. Cardiac biomarkers (eg, creatine kinase, troponin,
myoglobin)
Coagulation profile (eg, prothrombin time, activated partial
thromboplastin time)
Tests that measure the function of various organs, such as the
kidneys and liver. If these organs aren't working right, it could be a
sign that they aren't getting enough blood and oxygen, which could
be a sign of cardiogenic shock.
Brain natriuretic peptide (BNP) may be useful as an indicator of
congestive heart failure and as an independent prognostic indicator
of survival. A low BNP level may effectively rule out cardiogenic
shock in the setting of hypotension; however, an elevated BNP level
does not rule in the disease.
TreatmentEmergency life support- Emergency life support is a necessary
treatment for most people who have cardiogenic shock.
- Giving extra oxygen to breathe to minimize damage to your
muscles.
- If necessary, connected to a breathing machine (ventilator).
- Receiving medications and fluid through an intravenous (IV)
line in your arm.
Medication
Vasopressors- These drugs increase both coronary and cerebral
blood flow present during the low-flow state associated with shock.
Dopamine and dobutamine are the drugs of choice to improve
cardiac contractility.
Dopamine (Intropin)- 5-20 mcg/kg/min IV continuous infusion;
increase by 1-4 mcg/kg/min q10-30min to optimal response.
Dobutamine (Dobutrex)- 5-20 mcg/kg/min IV continuous infusion.
Phosphodiesterase enzyme inhibitors- These agents improve cardiac
output in refractory hypotension and shock. Milrinone and
inamrinone (formerly amrinone) may be used.
Milrinone- Loading dose: 50 mcg/kg IV over 10 min
infusion: 0.375-0.75 mcg/kg/min IV

Continuous

Inamrinone- Initial bolus: 0.75 mg/kg IV slowly over 2-3 min.
Maintenance infusion: 5-10 mcg/kg/min IV; not to exceed 10 mg/kg;
adjust dose according to response.
Platelet Aggregation Inhibitors- Agents that irreversibly inhibit
platelet aggregation may improve morbidity.
Aspirin- 160-324 mg PO or chewed;
Vasodilators- Smooth-muscle relaxers and vasodilators that can
reduce systemic vascular resistance, allowing more forward flow and
improving cardiac output.
Nitroglycerin- 10-20 mcg/min IV infusion.
Analgesics- Pain control

Morphine sulphate

Diuretics- drugs cause diuresis to decrease plasma volume and
edema and thereby decrease cardiac output BP
Furosemide (Lasix)- 40-80 mg/d IV/IM
Natriuretic peptide- These drugs cause arterial and venous dilation
by binding to cyclic GMP receptor on vascular smooth muscle
causing smooth muscle relaxation.
Nesiritide- Initial 2 mcg/kg IV bolus over 30 min followed by
continuous infusion at 0.01 mcg/kg/min
Medical procedures
Medical procedures to treat cardiogenic shock usually focus on
restoring blood flow through heart. They include:
Angioplasty and stenting. Emergency angioplasty opens blocked
coronary arteries, letting blood flow more freely to heart. Doctors
insert a long, thin tube (catheter) that's passed through an artery,
usually in leg, to a blocked artery in heart. This catheter is equipped
with a special balloon tip. Once in position, the balloon tip is briefly
inflated to open up a blocked coronary artery. At the same time, a
metal mesh stent may be inserted into the artery to keep it open
long term, restoring blood flow to the heart. Depending on
condition, doctor may opt to place a stent coated with a slowreleasing medication to help keep your artery open.
Balloon pump. Depending on condition, doctors may choose to
insert a balloon pump in the main artery of heart (aorta). The balloon
pump inflates and deflates to mimic the pumping action of your
heart, helping blood flow through.
Surgery
If medications and medical procedures don't work to treat
cardiogenic shock, your doctor may recommend surgery.
Coronary artery bypass surgery. Bypass surgery involves sewing
veins or arteries in place at a site beyond a blocked or narrowed
coronary artery (bypassing the narrowed section). This restores
blood flow to the heart.
Surgery to repair an injury to your heart. Sometimes, an injury in
heart, such as a tear in one of heart's chambers or a damaged heart
valve, can cause cardiogenic shock. If an injury is causing cardiogenic
shock, doctor may recommend surgery to correct the problem.
Heart pumps. These mechanical devices, called left ventricular assist
devices (LVADs), are implanted into the abdomen and attached to a
weakened heart to help it pump. Implanted heart pumps can
significantly extend and improve the lives of some people with endstage heart failure who aren't eligible for or able to undergo heart
transplantation or are waiting for a new heart.
Heart transplant. If heart is so damaged that no other treatments
work, a heart transplant may be a last resort for treating cardiogenic
shock.

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Ectopic Beats
Ectopic BeatsEctopic Beats
Ectopic Beats
 
tachyarrythmias d
tachyarrythmias dtachyarrythmias d
tachyarrythmias d
 
Valvular heart disease
Valvular heart diseaseValvular heart disease
Valvular heart disease
 
Percutaneous Coronary Intervention
Percutaneous Coronary InterventionPercutaneous Coronary Intervention
Percutaneous Coronary Intervention
 
Cardiac cath complications
Cardiac cath complicationsCardiac cath complications
Cardiac cath complications
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Echo in cardiomyopathies part 1
Echo in cardiomyopathies part 1Echo in cardiomyopathies part 1
Echo in cardiomyopathies part 1
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
 
MYOCARDIAL INFARCTION
MYOCARDIAL INFARCTIONMYOCARDIAL INFARCTION
MYOCARDIAL INFARCTION
 
Cardiac tumors
Cardiac tumorsCardiac tumors
Cardiac tumors
 
Heart failure
Heart failureHeart failure
Heart failure
 
Aortic Regurgitation
Aortic RegurgitationAortic Regurgitation
Aortic Regurgitation
 
Non infarction Q waves
Non infarction Q wavesNon infarction Q waves
Non infarction Q waves
 
Acute coronary syndrome (acs)
Acute coronary syndrome (acs)Acute coronary syndrome (acs)
Acute coronary syndrome (acs)
 
Treadmill test in cardiology
Treadmill test in cardiologyTreadmill test in cardiology
Treadmill test in cardiology
 
CARDIOGENIC SHOCK
CARDIOGENIC SHOCKCARDIOGENIC SHOCK
CARDIOGENIC SHOCK
 
ISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASEISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASE
 
Echocardiography an introduction
Echocardiography an introductionEchocardiography an introduction
Echocardiography an introduction
 
Tricuspid stenosis
Tricuspid stenosisTricuspid stenosis
Tricuspid stenosis
 
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
 

Destaque

Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shockdrucsamal
 
Cardiogenic shock : Medical Surgical Nursing
Cardiogenic shock : Medical Surgical NursingCardiogenic shock : Medical Surgical Nursing
Cardiogenic shock : Medical Surgical NursingRaksha Yadav
 
Cardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasCardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasAndrew Ferguson
 

Destaque (6)

Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Cardiogenic shock : Medical Surgical Nursing
Cardiogenic shock : Medical Surgical NursingCardiogenic shock : Medical Surgical Nursing
Cardiogenic shock : Medical Surgical Nursing
 
shock
shockshock
shock
 
Cardiogenic Shock
Cardiogenic ShockCardiogenic Shock
Cardiogenic Shock
 
Cardiogenic Shock And Arrhythmias
Cardiogenic Shock And ArrhythmiasCardiogenic Shock And Arrhythmias
Cardiogenic Shock And Arrhythmias
 

Semelhante a Cardiogenic shock

CARDIOGENIC SHOCK.pptx
CARDIOGENIC SHOCK.pptxCARDIOGENIC SHOCK.pptx
CARDIOGENIC SHOCK.pptxTowar Shilshi
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarctionPriya
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shockPriya
 
Shock and Management
Shock and  ManagementShock and  Management
Shock and ManagementV4Veeru25
 
Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)VIGNESHROSS
 
What is Blood pressure
What is Blood pressureWhat is Blood pressure
What is Blood pressureSrikanth KS
 
Heart Slides
Heart SlidesHeart Slides
Heart SlidesSatnam
 
M5 - Angina
M5 - AnginaM5 - Angina
M5 - AnginaBibul2
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsJoisy Aloor
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failurePriya
 
Cardiogenic Shock.pptx
Cardiogenic Shock.pptxCardiogenic Shock.pptx
Cardiogenic Shock.pptxprasannroy1
 
Cardiac tamponade lesson plan
Cardiac tamponade lesson planCardiac tamponade lesson plan
Cardiac tamponade lesson planSowmya Shetty
 
Cardiovascular Procedures
Cardiovascular ProceduresCardiovascular Procedures
Cardiovascular Procedurestkasprowicz
 
Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxImanuIliyas
 
Lecture 8 hypertension - Pathology
Lecture 8 hypertension - Pathology Lecture 8 hypertension - Pathology
Lecture 8 hypertension - Pathology Areej Abu Hanieh
 

Semelhante a Cardiogenic shock (20)

Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
CARDIOGENIC SHOCK.pptx
CARDIOGENIC SHOCK.pptxCARDIOGENIC SHOCK.pptx
CARDIOGENIC SHOCK.pptx
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
hypertension
hypertensionhypertension
hypertension
 
cardiac medicine
cardiac medicinecardiac medicine
cardiac medicine
 
Shock and Management
Shock and  ManagementShock and  Management
Shock and Management
 
Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)
 
Cardiac emergencies
Cardiac emergenciesCardiac emergencies
Cardiac emergencies
 
What is Blood pressure
What is Blood pressureWhat is Blood pressure
What is Blood pressure
 
Heart Slides
Heart SlidesHeart Slides
Heart Slides
 
M5 - Angina
M5 - AnginaM5 - Angina
M5 - Angina
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. Diagnostics
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Cardiogenic Shock.pptx
Cardiogenic Shock.pptxCardiogenic Shock.pptx
Cardiogenic Shock.pptx
 
Cardiac tamponade lesson plan
Cardiac tamponade lesson planCardiac tamponade lesson plan
Cardiac tamponade lesson plan
 
Cardiovascular Procedures
Cardiovascular ProceduresCardiovascular Procedures
Cardiovascular Procedures
 
Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptx
 
Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86
 
Lecture 8 hypertension - Pathology
Lecture 8 hypertension - Pathology Lecture 8 hypertension - Pathology
Lecture 8 hypertension - Pathology
 

Mais de Bhagyashri Shinde (20)

Anaesthesia
AnaesthesiaAnaesthesia
Anaesthesia
 
Ophthalmo glossary
Ophthalmo glossaryOphthalmo glossary
Ophthalmo glossary
 
Evidence based medicine pdf
Evidence based medicine pdfEvidence based medicine pdf
Evidence based medicine pdf
 
162 classification of cardiac arrhythmias and conduction disturbances
162 classification of cardiac arrhythmias and conduction disturbances162 classification of cardiac arrhythmias and conduction disturbances
162 classification of cardiac arrhythmias and conduction disturbances
 
Status asthmaticus
Status asthmaticusStatus asthmaticus
Status asthmaticus
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Psychiatry examination questions
Psychiatry examination questionsPsychiatry examination questions
Psychiatry examination questions
 
Pneumothorax
PneumothoraxPneumothorax
Pneumothorax
 
Pacemakers
PacemakersPacemakers
Pacemakers
 
Medical case report_ravi_chang_final
Medical case report_ravi_chang_finalMedical case report_ravi_chang_final
Medical case report_ravi_chang_final
 
Medical case report
Medical case reportMedical case report
Medical case report
 
Kidney colic
Kidney colicKidney colic
Kidney colic
 
Dx rx of_mi
Dx rx of_miDx rx of_mi
Dx rx of_mi
 
Cpr
CprCpr
Cpr
 
Biliary colic
Biliary colicBiliary colic
Biliary colic
 
Anaphylactic shock
Anaphylactic shockAnaphylactic shock
Anaphylactic shock
 
24 peptic ulcer
24 peptic ulcer24 peptic ulcer
24 peptic ulcer
 
15 myocardial infarction
15 myocardial infarction15 myocardial infarction
15 myocardial infarction
 

Último

SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.pptraviapr7
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptraviapr7
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 

Último (20)

SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.ppt
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 

Cardiogenic shock

  • 1. Cardiogenic shock is a state in which a weakened heart isn't able to pump enough blood to meet the body's needs. It is a medical emergency and is fatal if not treated right away. The most common cause of cardiogenic shock is damage to the heart muscle from a severe heart attack. Not everyone who has a heart attack develops cardiogenic shock. In fact, less than 10 percent of people who have a heart attack develop it. But when cardiogenic shock does occur, it's very dangerous. For people who die from a heart attack in a hospital, cardiogenic shock is the most common cause. The medical term "shock" refers to a state in which not enough blood and oxygen reach important organs in the body, such as the brain and kidneys. In a state of shock, a person's blood pressure is very low. When a person is in shock (from any cause), not enough blood or oxygen is reaching the body's organs. If shock lasts more than several minutes, the lack of oxygen to the organs starts to damage them. If shock isn't treated quickly, the organ damage can become permanent, and the person can die. Pathophysiology The most common initiating event in cardiogenic shock is AMI. Dead myocardium does not contract, and classical teaching has been that when more than 40% of the myocardium is irreversibly damaged (particularly, the anterior cardiac wall), cardiogenic shock may result. On a mechanical level, a marked decrease in contractility reduces the ejection fraction and cardiac output. These lead to increased ventricular filling pressures, cardiac chamber dilatation,
  • 2. and ultimately univentricular or biventricular failure that result in systemic hypotension and/or pulmonary edema. A systemic inflammatory response syndrome–type mechanism has been implicated in the pathophysiology of cardiogenic shock. Elevated levels of white blood cells, body temperature, complement, interleukins, and C-reactive protein are often seen in large myocardial infarctions. Similarly, inflammatory nitric oxide synthetase (iNOS) is also released in high levels during myocardial stress. iNOS induces nitric oxide production, which may uncouple calcium metabolism in the myocardium resulting in a stunned myocardium. Additionally, iNOS leads to the expression of interleukins, which may themselves cause hypotension. Myocardial ischemia causes a decrease in contractile function, which leads to left ventricular dysfunction and decreased arterial pressure; these, in turn, exacerbate the myocardial ischemia. The end result is a vicious cycle that leads to severe cardiovascular decompensation. Causes  The vast majority of cases of cardiogenic shock in adults are due to acute myocardial ischemia.  Systolic -Beta-blocker overdose, calcium channel blocker overdose, myocardial contusion, respiratory acidosis, hypocalcemia, hypophosphatemia, and cardiotoxic drugs (eg, doxorubicin [Adriamycin])  Diastolic - Ventricular hypertrophy and restrictive cardiomyopathies
  • 3.  After load -Aortic stenosis, hypertrophic cardiomyopathy, dynamic outflow obstruction, aortic coarctation, and malignant hypertension  Valvular/structural -Mitral stenosis, endocarditis, myocarditis, mitral or aortic regurgitation, atrial myxoma or thrombus, pericardial tamponade & pulmonary embolism.  Risk factors for the development of cardiogenic shock include preexisting myocardial damage or disease (eg, diabetes, advanced age, previous AMI(acute MI), AMI (eg, Q-wave, large or anterior wall AMIs), congenital heart disease, and dysrhythmia. Signs & symptoms:  Profuse sweating, moist skin  Tachycardia & tachypnea  Restlessness, agitation, confusion due to decreased cerebral perfusion and subsequent hypoxia.  Skin that feels cool to the touch  Pale skin color or blotchy (mottled) skin  Rapid & Weak (thready) pulse  Decreased mental status - Loss of ability to concentrate & Loss of alertness  Decreased or no urine output  Hypotension due to decrease in cardiac output
  • 4.  Distended jugular veins due to increased jugular venous pressure. DiagnosisBlood pressure. very low blood pressure, the most common sign of shock. ECG (electrocardiogram). diagnose severe heart attack & and monitor heart's condition. Chest X-ray.. A chest X-ray shows whether the heart is enlarged or whether there is fluid in the lungs, which can be signs of cardiogenic shock. Echocardiography. This test uses sound waves to create a moving picture of your heart. Echocardiography provides information about the size and shape of your heart and how well your heart chambers and valves are working. The test also can identify areas of heart muscle that aren't contracting normally. Not enough blood is flowing to these areas. Coronary angiography. passing a catheter (a thin, flexible tube) through an artery in leg or arm to heart. The catheter can measure the pressure inside the various chambers of your heart. A dye that can be seen on X-ray is injected into the blood through the tip of the catheter. The dye allows to study the flow of blood through the heart and blood vessels and see any blockages that exist. Arterial blood gas measurement. In this test, a blood sample is taken from an artery to measure oxygen, carbon dioxide, and pH (acidity) in the blood.. Cardiac enzymes. When cells in the heart die, they release enzymes into the blood called markers or biomarkers. Measuring these
  • 5. markers can show whether the heart is damaged and the extent of the damage. Cardiac biomarkers (eg, creatine kinase, troponin, myoglobin) Coagulation profile (eg, prothrombin time, activated partial thromboplastin time) Tests that measure the function of various organs, such as the kidneys and liver. If these organs aren't working right, it could be a sign that they aren't getting enough blood and oxygen, which could be a sign of cardiogenic shock. Brain natriuretic peptide (BNP) may be useful as an indicator of congestive heart failure and as an independent prognostic indicator of survival. A low BNP level may effectively rule out cardiogenic shock in the setting of hypotension; however, an elevated BNP level does not rule in the disease. TreatmentEmergency life support- Emergency life support is a necessary treatment for most people who have cardiogenic shock. - Giving extra oxygen to breathe to minimize damage to your muscles. - If necessary, connected to a breathing machine (ventilator). - Receiving medications and fluid through an intravenous (IV) line in your arm. Medication Vasopressors- These drugs increase both coronary and cerebral blood flow present during the low-flow state associated with shock.
  • 6. Dopamine and dobutamine are the drugs of choice to improve cardiac contractility. Dopamine (Intropin)- 5-20 mcg/kg/min IV continuous infusion; increase by 1-4 mcg/kg/min q10-30min to optimal response. Dobutamine (Dobutrex)- 5-20 mcg/kg/min IV continuous infusion. Phosphodiesterase enzyme inhibitors- These agents improve cardiac output in refractory hypotension and shock. Milrinone and inamrinone (formerly amrinone) may be used. Milrinone- Loading dose: 50 mcg/kg IV over 10 min infusion: 0.375-0.75 mcg/kg/min IV Continuous Inamrinone- Initial bolus: 0.75 mg/kg IV slowly over 2-3 min. Maintenance infusion: 5-10 mcg/kg/min IV; not to exceed 10 mg/kg; adjust dose according to response. Platelet Aggregation Inhibitors- Agents that irreversibly inhibit platelet aggregation may improve morbidity. Aspirin- 160-324 mg PO or chewed; Vasodilators- Smooth-muscle relaxers and vasodilators that can reduce systemic vascular resistance, allowing more forward flow and improving cardiac output. Nitroglycerin- 10-20 mcg/min IV infusion. Analgesics- Pain control Morphine sulphate Diuretics- drugs cause diuresis to decrease plasma volume and edema and thereby decrease cardiac output BP Furosemide (Lasix)- 40-80 mg/d IV/IM
  • 7. Natriuretic peptide- These drugs cause arterial and venous dilation by binding to cyclic GMP receptor on vascular smooth muscle causing smooth muscle relaxation. Nesiritide- Initial 2 mcg/kg IV bolus over 30 min followed by continuous infusion at 0.01 mcg/kg/min Medical procedures Medical procedures to treat cardiogenic shock usually focus on restoring blood flow through heart. They include: Angioplasty and stenting. Emergency angioplasty opens blocked coronary arteries, letting blood flow more freely to heart. Doctors insert a long, thin tube (catheter) that's passed through an artery, usually in leg, to a blocked artery in heart. This catheter is equipped with a special balloon tip. Once in position, the balloon tip is briefly inflated to open up a blocked coronary artery. At the same time, a metal mesh stent may be inserted into the artery to keep it open long term, restoring blood flow to the heart. Depending on condition, doctor may opt to place a stent coated with a slowreleasing medication to help keep your artery open. Balloon pump. Depending on condition, doctors may choose to insert a balloon pump in the main artery of heart (aorta). The balloon pump inflates and deflates to mimic the pumping action of your heart, helping blood flow through. Surgery If medications and medical procedures don't work to treat cardiogenic shock, your doctor may recommend surgery. Coronary artery bypass surgery. Bypass surgery involves sewing veins or arteries in place at a site beyond a blocked or narrowed
  • 8. coronary artery (bypassing the narrowed section). This restores blood flow to the heart. Surgery to repair an injury to your heart. Sometimes, an injury in heart, such as a tear in one of heart's chambers or a damaged heart valve, can cause cardiogenic shock. If an injury is causing cardiogenic shock, doctor may recommend surgery to correct the problem. Heart pumps. These mechanical devices, called left ventricular assist devices (LVADs), are implanted into the abdomen and attached to a weakened heart to help it pump. Implanted heart pumps can significantly extend and improve the lives of some people with endstage heart failure who aren't eligible for or able to undergo heart transplantation or are waiting for a new heart. Heart transplant. If heart is so damaged that no other treatments work, a heart transplant may be a last resort for treating cardiogenic shock.